) Research nas not yet uncovered a treatment that effectively reduces the risk of relapse; i.e., no efficacious relapse prevention treatments exist. This research is designed to produce information on the nature of smoking relapse and to develop and evaluate a treatment intended to reduce an abstinent smoker's risk of relapse. Subjects in this research (N=480; 160 subjects per group) will all be abstinent following a brief smoking cessation treatment. For Brief Therapy subjects this will constitute their only treatment. For Brief Therapy + Net subjects, the brief cessation treatment will be followed by access to Internet sites that provide smoking cessation resources. Brief Therapy + CHESS subjects will be given access to the Comprehensive Health Enhancement Support System (CHESS) following the brief treatment. CHESS is a computer-based guided universe of information, emotional support, and problem-solving assistance. Exposure to the Internet or CHESS will continue for 4 months following a subject's quit date. For this grant, a version of CHESS will be created that specifically targets smoking relapse. This Relapse Prevention CHESS will be based upon the following notions: (1) either episodic events, or worsening trends in affective/withdrawal symptoms, or both can trigger a smoking lapse. (2) efficacious treatments exist that address these threats to abstinence, but these treatments are efficacious only while on-going. Therefore, the key to efficacious relapse prevention is to sustain consistent treatment involvement over the period of significant relapse risk. And, (3) because trends in affective/withdrawal symptoms presage smoking lapses, through daily tracking of a subject's symptoms, CHESS can accurately anticipate lapses and intervene prior to a lapse. This research project will therefore, develop and evaluate a novel, research-based strategy of relapse prevention. This strategy is designed to use computer-integrated treatments in a cost-effective manner, and is designed to be widely disseminated in concert with a variety of cessation programs. Other goals of this research are to assess smokers' acceptance and use of the relapse interventions, and to identify mechanisms through which the interventions produce their effects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
3P50CA084724-04S1
Application #
6661426
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Teitelbaum, A M; Murphy, S E; Akk, G et al. (2018) Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain. Pharmacogenomics J 18:136-143
Guerreiro, Rita; Ross, Owen A; Kun-Rodrigues, Celia et al. (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64-74
Glasheen, Cristie; Johnson, Eric O; Saccone, Nancy L et al. (2018) Is the Fagerström test for nicotine dependence invariant across secular trends in smoking? A question for cross-birth cohort analysis of nicotine dependence. Drug Alcohol Depend 185:127-132
Singh, Tarjinder; Walters, James T R; Johnstone, Mandy et al. (2017) The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet 49:1167-1173
Peckham-Gregory, Erin C; Chakraborty, Rikhia; Scheurer, Michael E et al. (2017) A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility. Blood 130:2229-2232
Taylor, Kimberly E; Wong, Quenna; Levine, David M et al. (2017) Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry. Arthritis Rheumatol 69:1294-1305
Mercati, O; Huguet, G; Danckaert, A et al. (2017) CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders. Mol Psychiatry 22:625-633
Chen, Li-Shiun; Baker, Timothy; Brownson, Ross C et al. (2017) Smoking Cessation and Electronic Cigarettes in Community Mental Health Centers: Patient and Provider Perspectives. Community Ment Health J 53:695-702
Johnson, Eric O; Hancock, Dana B; Levy, Joshua L et al. (2016) KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. Addict Biol 21:1217-1232
Rees, Elliott; Kendall, Kimberley; Pardiñas, Antonio F et al. (2016) Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia. JAMA Psychiatry 73:963-969

Showing the most recent 10 out of 86 publications